Vital Farms (NASDAQ:VITL) Reaches New 52-Week Low on Disappointing Earnings

Key Points

• Vital Farms' stock hit a new 52-week low (trading as low as $8.40, last $9.52) after reporting Q1 GAAP EPS of ($0.03), missing the $0.09 consensus and contributing to a roughly 20.7% drop in the share price.
• While revenue beat at $187.2M (up ~15% YoY), management cut FY‑2026 revenue guidance to about $775M–$800M versus street expectations near $871.6M, which materially weakened forward earnings visibility.
• The company is contending with multiple class‑action suits and investigations alleging it misled investors (including claims about ERP implementation disruptions), increasing legal risk and investor uncertainty.

Vital Farms, Inc. (NASDAQ:VITL - Get Free Report)'s stock price hit a new 52-week low during trading on Thursday following a dissappointing earnings announcement. The company traded as low as $8.40 and last traded at $9.52, with a volume of 19552914 shares. The stock had previously closed at $12.00.

The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.12). The business had revenue of $187.16 million during the quarter, compared to the consensus estimate of $182.40 million. Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.Vital Farms's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 earnings per share.

Key Vital Farms News

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Revenue beat and growth — Vital Farms reported Q1 revenue of $187.2M, above consensus (~$182.4M) and up ~15% year‑over‑year, showing ongoing top‑line demand for the company’s products. Zacks: Vital Farms Reports Q1
• Neutral Sentiment: Profitability metrics mixed — the company posted a net margin of 8.73% and a return on equity of 20.69%, which indicate underlying profitability despite the quarterly EPS swing; investors can review the company’s press release and slide deck for more detail. Vital Farms Press Release / Slide Deck
• Negative Sentiment: EPS miss — Q1 GAAP EPS was a loss of $0.03 versus a consensus profit estimate of $0.09, a notable swing from $0.37 a year earlier; earnings disappointment increases near‑term downside pressure. Zacks: Q1 EPS Miss
• Negative Sentiment: Guidance shortfall — management trimmed FY‑2026 revenue guidance to roughly $775M–$800M vs. street consensus near $871.6M, a sizable gap that materially weakens forward earnings visibility and likely drove selling. (See company materials linked above for the guidance range.)
• Negative Sentiment: Multiple class‑action suits and investigations — several law firms have filed or announced investigations alleging Vital Farms misled investors (claims reference the May 8, 2025–Feb 26, 2026 class period), and at least one complaint alleges the company concealed ERP implementation disruptions; legal risk and potential future liabilities add to investor uncertainty. Robbins LLP: Class Action Notice Levi & Korsinsky: ERP Allegation

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Morgan Stanley dropped their price target on Vital Farms from $24.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 23rd. Mizuho set a $20.00 price target on Vital Farms in a research report on Monday. DA Davidson restated a "neutral" rating and set a $16.00 price target (down from $47.00) on shares of Vital Farms in a research report on Monday. Craig Hallum dropped their target price on Vital Farms from $55.00 to $20.00 and set a "buy" rating on the stock in a report on Thursday, April 2nd. Finally, Benchmark downgraded Vital Farms from a "buy" rating to a "hold" rating in a report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $32.42.

Insider Buying and Selling at Vital Farms

In other news, major shareholder Matthew Ohayer sold 20,000 shares of the business's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $20.33, for a total value of $406,600.00. Following the completion of the transaction, the insider owned 6,321,190 shares in the company, valued at $128,509,792.70. The trade was a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Karl Khoury purchased 5,000 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was acquired at an average price of $18.45 per share, with a total value of $92,250.00. Following the purchase, the director directly owned 119,789 shares of the company's stock, valued at approximately $2,210,107.05. The trade was a 4.36% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 21.30% of the stock is owned by insiders.

Institutional Trading of Vital Farms

A number of hedge funds have recently bought and sold shares of VITL. Royal Bank of Canada grew its holdings in Vital Farms by 89.2% during the first quarter. Royal Bank of Canada now owns 19,381 shares of the company's stock valued at $591,000 after purchasing an additional 9,136 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Vital Farms by 5.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company's stock valued at $611,000 after purchasing an additional 1,108 shares during the period. Goldman Sachs Group Inc. grew its holdings in Vital Farms by 3.3% during the first quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company's stock valued at $12,658,000 after purchasing an additional 13,397 shares during the period. Woodline Partners LP bought a new stake in Vital Farms during the first quarter valued at about $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Vital Farms by 1.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company's stock valued at $2,739,000 after purchasing an additional 1,198 shares during the period. Hedge funds and other institutional investors own 98.59% of the company's stock.

Vital Farms Stock Down 20.7%

The company has a fifty day simple moving average of $14.91 and a 200-day simple moving average of $25.49. The company has a quick ratio of 1.61, a current ratio of 2.16 and a debt-to-equity ratio of 0.01. The firm has a market cap of $407.93 million, a P/E ratio of 6.61 and a beta of 1.20.

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms' supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.